electroCore Announces the Commercial Launch of TAC-STIM™
June 25, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce the Commercial Off the...
electroCore to Join Russell Microcap® Index
June 11, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its stock is on the...
Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
June 10, 2024 03:00 ET
|
Amber Therapeutics
US approval would make Amber-UI the first fully implantable adaptive neuromodulation therapy for women with mixed urinary incontinence (MUI)By targeting the pudendal nerve, Amber-UI has the unique...
electroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
June 06, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced...
electroCore Announces First Quarter 2024 Financial Results
May 08, 2024 16:05 ET
|
electroCore, Inc.
Record first quarter 2024 net sales of $5.4 million, an increase of 96% over first quarter 2023Company to host a conference call and webcast today, May 8, 2024 at 4:30 PM EST ROCKAWAY, N.J., May 08,...
electroCore Expands Intellectual Property Portfolio
April 02, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., April 02, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue...
Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
February 27, 2024 09:00 ET
|
Amber Therapeutics
Key initial results from AURA-2 study highlight good safety and scalability of Amber-UI therapy A strong efficacy signal was seen in the form of complete resolution of incontinence episodes six months...
Smart Medical Devices Market Expecting to Hit USD 474 Billion by 2032, with a CAGR of 12.3 % | Market.us
December 13, 2023 05:28 ET
|
Market.Us
New York, Dec. 13, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Smart Medical Devices Market size is expected to be worth around USD 474 Billion by 2032 from USD...
Oxford Science Enterprises strengthens Health Tech team with appointments of two new Entrepreneurs in Residence
November 01, 2023 05:00 ET
|
Oxford Science Enterprises
Katherine Ward, former Chief Commercial Officer of digital health tech start-up Healthy.io and Nate Notwell, former Head of North America Consumer Experience at Kenvue, appointed to spur company...
Five-in-one CS 9600 3D System is a Five-time Cellerant Best of Class Technology Award Winner
September 05, 2023 09:08 ET
|
Carestream Dental
Atlanta, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Continual innovation and market-leading technology has earned Carestream Dental’s CS 9600 CBCT system its fifth-straight Cellerant Best of Class...